Picture of Royalty Pharma logo

RPRX — Royalty Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Beigene And Unit Sign Royalty Purchase Agreement With Royalty Pharma PLC's Unit

Aug 25 (Reuters) - Beigene Ltd 688235.SS:

SAY CO, UNIT SIGN ROYALTY PURCHASE AGREEMENT WITH ROYALTY PHARMA INVESTMENTS 2023 ICAV, UNIT OF ROYALTY PHARMA PLC

SAYS AGREED TO SELL RIGHTS TO ROYALTIES ON IMDELLTRA SALES OUTSIDE CHINA TO ROYALTY PHARMA INVESTMENTS 2023 ICAV FOR $885 MILLION UPFRONT

Source text

Further company coverage: 688235.SS

 (Reporting by Beijing Newsroom)

 ((Shi.Bu@thomsonreuters.com;))

Recent news on Royalty Pharma

See all news